Your SlideShare is downloading. ×
Dermatological Therapeutics: Global Markets - Download this ...
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Dermatological Therapeutics: Global Markets - Download this ...

813

Published on

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
813
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
18
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. ReportLinker Find Industry reports, Company profiles and Market Statistics >> Download this market research report on Reportlinker.com Dermatological Therapeutics: Global Markets Published on January 2009 Report Summary INTRODUCTION STUDY GOALS AND OBJECTIVES BCC's goal in conducting this study was to understand the current status of the U.S. dermatological therapeutics industry and to assess it in the medium term from 2008 through 2013. We were particularly interested in understanding the future market potential for the current and emerging technologies and products within the dermatological therapeutics industry. This report assesses the available therapeutic procedures for skin, along with the drugs and technologies currently being used for various skin treatments. The role of public agencies, the regulatory environment, and non-governmental stakeholders has also been examined. REASONS FOR DOING THIS STUDY Skin disorders have a high active as well as passive morbidity in most human populations across the world. Yet, most dermatology manufacturers and dermatologists rely on cosmetic applications and procedures for survival. INTENDED AUDIENCE This study is likely to be of interest to individuals and organizations involved in aspects of dermatological therapeutics industry, such as research, manufacturing and even large buyers in the industry. This report will also be of interest to manufacturers and marketers of dermatological therapeutics industry across the world. Table of Content CHAPTER ONE: INTRODUCTION STUDY GOALS AND OBJECTIVES REASONS FOR DOING THIS STUDY INTENDED AUDIENCE Dermatological Therapeutics: Global Markets Page 1/28
  • 2. ReportLinker Find Industry reports, Company profiles and Market Statistics SCOPE OF REPORT METHODOLOGY INFORMATION SOURCES ABOUT THE AUTHOR RELATED BCC RESEARCH REPORTS BCC ONLINE SERVICES DISCLAIMER CHAPTER TWO: SUMMARY SUMMARY TABLE GLOBAL DERMATOLOGICAL THERAPEUTICS REVENUE FORECAST BY MARKET SEGMENT, THROUGH 2013 ($ BILLIONS) SUMMARY FIGURE GLOBAL DERMATOLOGICAL THERAPEUTICS REVENUE FORECAST BY MARKET SEGMENT, 2008 AND 2013 (%) CHAPTER THREE: OVERVIEW HUMAN SKIN TABLE 1 FUNCTIONS OF THE SKIN TABLE 1 (CONTINUED) SKIN DISORDERS TABLE 2 DISORDERS OF THE SKIN TABLE 2 (CONTINUED) TABLE 2 (CONTINUED) TABLE 2 (CONTINUED) ACNE Dermatological Therapeutics: Global Markets Page 2/28
  • 3. ReportLinker Find Industry reports, Company profiles and Market Statistics TABLE 3 TYPES OF ACNE ROSACEA TABLE 4 TYPES OF ROSACEA TABLE 5 DRUGS AND THEIR ACTION AGAINST ACNE AND ROSACEA BACTERIAL INFECTIONS OF THE SKIN TABLE 6 TYPES OF BACTERIAL INFECTIONS OF THE SKIN TABLE 6 (CONTINUED) TABLE 6 (CONTINUED) TABLE 7 SOME PRESCRIPTION DRUGS PRESCRIBED TO TREAT BACTERIAL SKIN INFECTIONS TABLE 7 (CONTINUED) TABLE 7 (CONTINUED) BENIGN SKIN GROWTHS OR TUMORS TABLE 8 TYPES OF BENIGN SKIN GROWTHS OR TUMORS TABLE 8 (CONTINUED) TABLE 9 SOME PRESCRIPTION DRUGS USED TO TREAT BENIGN SKIN GROWTHS TABLE 9 (CONTINUED) BULLOUS DISORDERS OR BLISTERING DISEASES TABLE 10 TYPES OF BULLOUS DISORDERS TABLE 10 (CONTINUED) TABLE 11 SOME PRESCRIPTION DRUGS USED TO TREAT BULLOUS SKIN DISORDERS TABLE 11 (CONTINUED) Dermatological Therapeutics: Global Markets Page 3/28
  • 4. ReportLinker Find Industry reports, Company profiles and Market Statistics SKIN CANCERS TABLE 12 TYPES OF SKIN CANCERS TABLE 12 (CONTINUED) Types of Melanoma Lentigo Maligna Melanoma Superficial Spreading Melanoma Nodular Melanoma Acral-Lentiginous Melanoma TABLE 13 SKIN CANCER INCIDENCE IN THE U.S TABLE 14 SOME PRESCRIPTION DRUGS USED TO TREAT CUTANEOUS CARCINOMAS CORNIFICATION DISORDERS Calluses and Corns TABLE 15 TYPES OF CALLUSES AND CORNS Ichthyosis or Dry Skin TABLE 16 TYPES OF ICHTHYOSIS TABLE 16 (CONTINUED) Keratosis Pilaris TABLE 17 TYPES OF KERATOSIS PILARIS Sebaceous Cysts Dermatitis Dermatological Therapeutics: Global Markets Page 4/28
  • 5. ReportLinker Find Industry reports, Company profiles and Market Statistics TABLE 18 TYPES OF DERMATITIS TABLE 18 (CONTINUED) TABLE 19 SOME DRUGS PRESCRIBED FOR DERMATITIS Fungal Infections of the Skin TABLE 20 TYPES OF FUNGAL INFECTIONS OF THE SKIN TABLE 20 (CONTINUED) TABLE 21 SOME DRUGS PRESCRIBED TO TREAT FUNGAL INFECTIONS OF THE SKIN TABLE 21 (CONTINUED) HYPERSENSITIVITY AND INFLAMMATORY DISORDERS Acute Febrile Neutrophilic Dermatosis (Sweet's Syndrome) Drug Eruptions and Reactions TABLE 22 TYPES OF DRUG REACTIONS AND TYPICAL CAUSATIVE AGENTS TABLE 22 (CONTINUED) Erythema Multiforme TABLE 23 TYPES OF ERYTHEMA MULTIFORME Erythema Nodosum Granuloma Annulare Panniculitis Pyoderma Gangrenosum Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Bed Sore Pityriasis Rosea Dermatological Therapeutics: Global Markets Page 5/28
  • 6. ReportLinker Find Industry reports, Company profiles and Market Statistics TABLE 24 SOME DRUGS PRESCRIBED TO TREAT HYPERSENSITIVITY AND INFLAMMATORY DISORDERS TABLE 24 (CONTINUED) PARASITIC INFECTIONS OF THE SKIN TABLE 25 TYPES OF PARASITIC INFECTION OF THE SKIN TABLE 25 (CONTINUED) TABLE 26 SOME DRUGS PRESCRIBED TO TREAT PARASITIC INFECTIONS OF THE SKIN PSORIASIS AND SCALING DISEASES TABLE 27 TYPES OF PSORIASIS AND SCALING DISEASES Psoriasis Treatment PIGMENTATION DISORDERS TABLE 28 TYPES OF PIGMENTATION DISORDERS Birthmarks Poison Ivy TABLE 29 SOME PRESCRIPTION DRUGS FOR PIGMENTATION DISORDERS REACTIONS TO SUNLIGHT Aging Actinic Keratoses Skin Cancers Photosensitivity TABLE 30 TYPES OF PHOTOSENSITIVITY Dermatological Therapeutics: Global Markets Page 6/28
  • 7. ReportLinker Find Industry reports, Company profiles and Market Statistics Sunburn SWEATING DISORDERS TABLE 31 TYPES OF SWEATING DISORDERS VIRAL SKIN DISEASES TABLE 32 TYPES OF VIRAL SKIN DISEASES TABLE 32 (CONTINUED) TABLE 33 SOME DRUGS PRESCRIBED TO TREAT VIRAL DISEASES OF THE SKIN TABLE 33 (CONTINUED) COMMON DIAGNOSTIC TESTS FOR SKIN DISORDERS DERMOSCOPY PATCH TESTING SKIN BIOPSY CULTURE PHOTOTESTS MORBIDITY/PREVALENCE TABLE 34 SKIN DISORDER MORBIDITY IN THE U.S. BY AGE AND CAUSE (THOUSANDS) THERAPEUTIC PROCEDURES FOR THE SKIN CANCER SURGERY Excisional Biopsy to Remove Skin Cancer Curettage and Electrocautery Mohs Micrographic Surgery (MMS) Wide Local Excision Dermatological Therapeutics: Global Markets Page 7/28
  • 8. ReportLinker Find Industry reports, Company profiles and Market Statistics Skin Grafting Lymph Node Removal CHEMICAL PEELS CRYOTHERAPY/CRYOSURGERY Ice Packs Cold Gel Packs Ice Immersion Ice Massage Vapocoolant Sprays RADIOTHERAPY CHEMOTHERAPY Chemotherapy Creams Chemotherapy into a Vein LASER SURGERY TABLE 35 SKIN CONDITIONS REQUIRING ONLY LASER SURGERY TABLE 35 (CONTINUED) TABLE 35 (CONTINUED) Carbon Dioxide Laser YAG Laser Pulsed Dye Laser or Argon Laser Excimer Laser TABLE 36 ADVANTAGES AND DISADVANTAGES OF EXCIMER LASER PHOTODYNAMIC THERAPY Dermatological Therapeutics: Global Markets Page 8/28
  • 9. ReportLinker Find Industry reports, Company profiles and Market Statistics TABLE 37 VARIOUS CANCERS TREATABLE BY PDT Application in Dermatology TABLE 38 VARIOUS SKIN DISORDERS TREATABLE BY PDT Goeckerman Treatment PUVA Ultraviolet B Phototherapy Broadband Narrowband TABLE 39 ADVANTAGES AND DISADVANTAGES OF UVB THERAPY SCLEROTHERAPY CHAPTER FOUR: PRESCRIPTION DERMATOLOGICAL DRUGS SYSTEMIC DRUGS ACITRETIN CLINDAMYCIN ERYTHROMYCIN CYCLOSPORINE TABLE 40 ADVANTAGES AND DISADVANTAGES OF CYCLOSPORINE METHOTREXATE TABLE 41 ADVANTAGES AND DISADVANTAGES OF METHOTREXATE THALIDOMIDE SYSTEMIC ANTIBACTERIAL AGENTS Dermatological Therapeutics: Global Markets Page 9/28
  • 10. ReportLinker Find Industry reports, Company profiles and Market Statistics Antileprotic Drugs (Including Dapsone) Antimalarial Drugs (Including Hydroxychloroquine) SYSTEMIC ANTIFUNGAL AGENTS SYSTEMIC ANTIHISTAMINES SYSTEMIC ANTIPARASITIC AGENTS SYSTEMIC ANTIPRURITIC AGENTS SYSTEMIC ANTIVIRAL AGENTS SYSTEMIC CORTICOSTEROIDS SYSTEMIC INTERFERONS SYSTEMIC RETINOID OTHER SYSTEMIC DRUGS 6-Thioguanine Hydroxyurea Mycophenolate Mofetil Sulfasalazine BIOLOGICAL THERAPIES (BIOLOGICS) Colchicine CYTOTOXIC AND IMMUNOSUPPRESSIVE DRUGS Retinoids Hormones and Anti-Androgens Hormones and ' (Continued) TOPICAL TREATMENTS ACICLOVIR TOPICAL RETINOIDS ANTHRALIN Dermatological Therapeutics: Global Markets Page 10/28
  • 11. ReportLinker Find Industry reports, Company profiles and Market Statistics TABLE 42 ADVANTAGES AND DISADVANTAGES OF ANTHRALIN COAL TAR TABLE 43 ADVANTAGES AND DISADVANTAGES OF COAL TAR CORTICOSTEROIDS TABLE 44 ADVANTAGES AND DISADVANTAGES OF CORTICOSTEROIDS TABLE 45 TOPICAL CORTICOSTEROIDS, 2004 TABLE 45 (CONTINUED) TABLE 45 (CONTINUED) RETINOID: TAZAROTENE TABLE 46 ADVANTAGES AND DISADVANTAGES OF TAZAROTENE VITAMIN D3: CALCIPOTRIENE TABLE 47 ADVANTAGES AND DISADVANTAGES OF CALCIPOTRIOL CAPSAICIN TOPICAL MEDICATIONS IN CLINICAL TRIALS MOISTURIZERS AND SCALE REMOVERS TABLE 48 DRUG TREATMENTS FOR SKIN DISEASE INTRODUCED IN 2006 TABLE 48 (CONTINUED) TABLE 48 (CONTINUED) TABLE 48 (CONTINUED) TABLE 48 (CONTINUED) Dermatological Therapeutics: Global Markets Page 11/28
  • 12. ReportLinker Find Industry reports, Company profiles and Market Statistics TABLE 48 (CONTINUED) CHAPTER FIVE: TECHNOLOGY REVIEW EMERGING TECHNOLOGIES IN DERMATOLOGY DNA MICROARRAY TECHNOLOGY IN DERMATOLOGY ADVANCES IN THE TREATMENT OF VARICOSE VEINS EMERGING TREATMENT OF ATOPIC DERMATITIS EMERGING DRUGS FOR ICHTHYOSIS PROGRESS IN THE MANAGEMENT OF ACNE PLASMA SKIN REGENERATION TECHNOLOGY TABLE 49 NEW TECHNOLOGIES IN DERMATOLOGY TABLE 49 (CONTINUED) PERMEATION ENHANCEMENT TECHNOLOGIES Drug Permeation Enhancement via Buccal Route Thiomatrix: Permeation Enhancement Merrion's Technology: Gastrointestinal Permeation Enhancement Technology (GIPET) FIGURE 1 GASTROINTESTINAL PERMEATION ENHANCEMENT TECHNOLOGY Transdermal Protein Delivery or Measurement Using Low-Frequency Sonophoresis RADIOTHERAPY External Radiotherapy Conformal Radiotherapy Intensity Modulated Radiotherapy Internal Radiotherapy Radioactive Implants Dermatological Therapeutics: Global Markets Page 12/28
  • 13. ReportLinker Find Industry reports, Company profiles and Market Statistics Radioactive Liquids Radioactive ' (Continued) PLASMA SKIN REGENERATION Plasma Skin ' (Continued) Plasma Skin ' (Continued) CHAPTER SIX: PATENT ANALYSIS PATENT ISSUE TRENDS IN UNITED STATES FIGURE 2 U.S. PATENT TRENDS, 1990-2001 TABLE 50 NUMBER OF U.S. PATENTS ISSUED, 2003 TO JULY 31, 2008 TABLE 51 COMPANIES AND NUMBER OF U.S. PATENTS FILED BY THEM, 2003 TO JULY 31, 2008 TABLE 52 RECENT DERMATOLOGY U.S. PATENTS TABLE 52 (CONTINUED) TABLE 52 (CONTINUED) TABLE 52 (CONTINUED) PATENT ISSUE TRENDS IN EUROPE TABLE 53 EUROPEAN DERMATOLOGICAL PATENTS, 2003-JULY 2008. TABLE 54 RECENT PATENTS ISSUED BY THE EPO TABLE 54 (CONTINUED) CHAPTER SEVEN: INDUSTRY PARTICIPANT PROFILES MANUFACTURERS OF DERMATOLOGICAL DRUGS AGI DERMATICS ALLERGAN, INC AMGEN, INC Dermatological Therapeutics: Global Markets Page 13/28
  • 14. ReportLinker Find Industry reports, Company profiles and Market Statistics ANACOR PHARMACEUTICALS ANIKA THERAPEUTICS, INC ASTELLAS US, LLC CHESTER VALLEY PHARMACEUTICALS, INC CORIA LABORATORIES, LTD CORIA LABORATORIES, LTD DERMIK LABORATORIES, INC DUSA PHARMACEUTICALS, INC. EISAI, INC. FERNDALE LABORATORIES, INC. GALDERMA LABORATORIES GENENTECH, INC. ISOLAGEN, INC. LEO PHARMA A/S MEDICIS PHARMACEUTICAL CORP MEDIMETRIKS PHARMACEUTICALS, INC. MERZ PHARMA UK, LTD. NEOSIL, INC. NYCOMED U.S., INC. OBAGI MEDICAL PRODUCTS, INC. ONSET THERAPEUTICS ORTHONEUTROGENA PIERRE FABRE PHARMACEUTICALS, INC PRIME PHARMACEUTICALS CORP QLT, INC. Dermatological Therapeutics: Global Markets Page 14/28
  • 15. ReportLinker Find Industry reports, Company profiles and Market Statistics QUINNOVA PHARMACEUTICALS SCHERING-PLOUGH CORP SINCLAIR PHARMACEUTICALS SKINMEDICA, INC. STIEFEL LABORATORIES, INC. SUMMERS LABORATORIES, INC SYNTOPIX GROUP, PLC TRIAX PHARMACEUTICALS, LLC VALEANT PHARMACEUTICALS INTERNATIONAL VALEO PHARMA, INC. WARNER CHILCOTT, LTD XOMA, LTD NON-COMMERCIAL ORGANIZATIONS AFRICAN ASSOCIATION OF DERMATOLOGY AMERICAN ACADEMY OF DERMATOLOGY (AAD) AMERICAN BEHCET'S DISEASE ASSOC., INC AMERICAN CELIAC SOCIETY AMERICAN HEMOCHROMATOSIS SOCIETY, INC AMERICAN LUPUS SOCIETY AMERICAN SKIN ASSOCIATION, INC AMERICAN SOCIAL HEALTH ASSOC ARTHRITIS FOUNDATION ASIAN DERMATOLOGICAL ASSOCIATION ASSOCIATION OF PROFESSORS OF DERMATOLOGY ATAXIA-TELANGIECTASIA CHILDREN'S PROJECT Dermatological Therapeutics: Global Markets Page 15/28
  • 16. ReportLinker Find Industry reports, Company profiles and Market Statistics BASAL CELL CARCINOMA NEVUS SYNDROME/GORLIN SYNDROME BAY AREA LUPUS FOUNDATION BLOOM'S SYNDROME REGISTRY BRITISH ASSOCIATION OF DERMATOLOGISTS CELIAC DISEASE FOUNDATION CELIAC SPRUE ASSOCIATION/USA CICATRICIAL ALOPECIA RESEARCH FOUNDATION COALITION OF SKIN DISEASES CORNELIA DE LANGE SYNDROME FOUNDATION, INC CUTANEOUS LYMPHOMA FOUNDATION DERMATOLOGY FOUNDATION DERMATOLOGY NURSES ASSOCIATION (DNA) DERMATOPATHOLOGY FOUNDATION DYSAUTONOMIA FOUNDATION, INC DYSTROPHIC EPIDERMOLYSIS BULLOSA THE ECTODERMAL DYSPLASIA SOCIETY EHLERS DANLOS NATIONAL FOUNDATION (EDNF) EHLERS-DANLOS SYNDROME FOUNDATION EUROPEAN ACADEMY FOR DERMATOLOGY AND VENEREOLOGY EADV Administrative Office THE EUROPEAN DERMATOLOGY FORUM EUROPEAN SOCIETY FOR DERMATOLOGICAL RESEARCH EUROPEAN UNION OF MEDICAL SPECIALISTS FOUNDATION FOR ICHTHYOSIS AND RELATED SKIN TYPES (F.I.R.S.T.) Dermatological Therapeutics: Global Markets Page 16/28
  • 17. ReportLinker Find Industry reports, Company profiles and Market Statistics GLUTEN INTOLERANCE GROUP (DERMATITIS HERPETIFORMIS) HEMOCHROMATOSIS RESEARCH FOUNDATION HIDRADENITIS SUPPURATIVA FOUNDATION, INC HISTIOCYTOSIS ASSOCIATION OF AMERICA INFLAMMATORY SKIN DISEASE INSTITUTE (ISDI) INTERNATIONAL FOUNDATION FOR DERMATOLOGY THE INTERNATIONAL LEAGUE OF DERMATOLOGICAL SOCIETIES OFFICE INTERNATIONAL PEMPHIGUS PEMPHIGOID FOUNDATION THE INTERNATIONAL SOCIETY OF DERMATOPATHOLOGY KLIPPEL-TRENAUNAY SUPPORT GROUP LUPUS FOUNDATION OF AMERICA, INC. LYMPHOMA RESEARCH FOUNDATION LYMPHOMATOID PAPULOSIS CENTRAL REGISTRY MARFAN ASSOC. U.K. THE MELANOMA RESEARCH FOUNDATION MUSCULAR DYSTROPHY ASSOC MYOSITIS ASSOCIATION OF AMERICA (MAA) NATIONAL ALOPECIA AREATA FOUNDATION (NAAF) NATIONAL ATAXIA FOUNDATION NATIONAL ECZEMA ASSOCIATION (NEA) NATIONAL ECZEMA ASSOCIATION FOR SCIENCE AND EDUCATION NATIONAL ECZEMA SOCIETY NATIONAL EPIDERMOLYSIS BULLOSA REGISTRY NATIONAL FOUNDATION FOR ECTODERMAL DYSPLASIAS NATIONAL FOUNDATION FOR VITILIGO AND PIGMENT DISORDERS Dermatological Therapeutics: Global Markets Page 17/28
  • 18. ReportLinker Find Industry reports, Company profiles and Market Statistics NATIONAL INCONITENTIA PIGMENTI FOUNDATION NATIONAL MEDICAL ASSOC NATIONAL NEUROFIBROMATOSIS FOUNDATION NATIONAL ORGANIZATION FOR ALBINISM AND HYPOPIGMENTATION (NOAH) NATIONAL ORGANIZATION FOR RARE DISORDERS (NORD) THE NATIONAL PEMPHIGUS FOUNDATION NATIONAL PSORIASIS FOUNDATION NATIONAL REGISTRY FOR ICHTHYOSIS AND RELATED DISORDERS NATIONAL VITILIGO FOUNDATION NEVOID BASAL CELL CARCINOMA SYNDROME SUPPORT NETWORK PACHYONYCHIA CONGENITA PROJECT THE PSORIASIS ASSOC. SCLERODERMA FEDERATION, INC SCLERODERMA FOUNDATION SCLERODERMA RESEARCH FOUNDATION THE SCLERODERMA SOCIETY SOCIETY FOR INVESTIGATIVE DERMATOLOGY (SID) SOCIETY FOR PEDIATRIC DERMATOLOGY (SPD) THE STURGE-WEBER FOUNDATION THE VITILIGO SOCIETY, U.K. VITILIGO SUPPORT INTERNATIONAL VZV RESEARCH FOUNDATION XERODERMA PIGMENTOSUM SOCIETY TABLE 55 DERMATOLOGICAL ASSOCIATIONS Dermatological Therapeutics: Global Markets Page 18/28
  • 19. ReportLinker Find Industry reports, Company profiles and Market Statistics TABLE 55 (CONTINUED) STRATEGIC ALLIANCES IN THE DERMATOLOGY MARKET MERGERS & ACQUISITIONS TABLE 56 SIGNIFICANT MERGERS AND ACQUISITIONS (2005-2008) TABLE 56 (CONTINUED) TABLE 56 (CONTINUED) VENTURE CAPITAL DEALS CHAPTER EIGHT: REGULATORY PREVIEW DRUG REGULATION IN THE UNITED STATES LICENSES FOR MEDICAL DEVICES DRUG REGULATION IN THE UNITED KINGDOM LICENSES FOR DRUGS DRUG AND EQUIPMENT APPROVAL IN EUROPE LICENSES FOR MEDICAL EQUIPMENT REIMBURSEMENT FOR DERMATOLOGICAL TREATMENT REIMBURSEMENT IN THE UNITED STATES REIMBURSEMENT IN EUROPE Reimbursement in Europe (Continued) CHAPTER NINE: MARKET METRICS MARKET TRENDS BIG PHARMA'S FOCUS ON BLOCKBUSTER DRUGS ENABLES SPECIALTY FOCUS BY SMALL AND MEDIUM-SIZED FIRMS COSMETIC/AESTHETIC DERMATOLOGY FACES DOWNTURN CHANGES IN REIMBURSEMENT AND OTHER LEGISLATION ARE CREATING UNCERTAINTY Managed Care Issues Dermatological Therapeutics: Global Markets Page 19/28
  • 20. ReportLinker Find Industry reports, Company profiles and Market Statistics Medical Liability Physician Quality Reporting Initiative (PQRI) Dermatologic Surgery Cosmetic Procedure Tax INCREASED USE OF GENERICS IN PRESCRIPTION DERMATOLOGY DIFFICULTIES IN DETERMINATION OF BIOAVAILABILITY OF TOPICAL DRUGS PHYSICIAN SHORTAGE AND PARAMEDIC INFLUX IN DERMATOLOGY CERTIFICATION EXAM FOR NURSE PRACTITIONERS IN DERMATOLOGY NOW AVAILABLE USE OF PROCEDURE-THERAPY AND SPECIFIC DRUGS IN DERMATOLOGY POLLUTION CONTRIBUTES TO RISE IN ATOPIC DERMATITIS MANUFACTURERS OF TNF-BLOCKER DRUGS ORDERED TO HIGHLIGHT RISK OF FUNGAL INFECTIONS HIGHER CO-PAYS FOR BIOLOGICS IMPACTS PRESCRIPTIONS U.S. DERMATOLOGICAL MARKET TABLE 57 LEADING DRUGS PRESCRIBED BY OFFICE-BASED DERMATOLOGISTS'ALL INDICATIONS, 2008 (THOUSANDS) PRESCRIPTION DATA FOR ACNE Prescription Data for Acne (Continued) FIGURE 3 PRESCRIBING OF ORAL ANTIBIOTICS FOR THE INTITIAL TREATMENT OF ACNE: CURRENT AND IN 1 YEAR (N=75) FIGURE 4 PRESCRIBING OF TOPICAL ANTIBIOTICS/RETINOIDS FOR ACNE: CURRENT AND IN 1 YEAR (N=75) TABLE 58 U.S. DERMATOLOGICAL THERAPEUTICS MARKET: REVENUE FORECAST BY MARKET SEGMENT, THROUGH 2013 ($BILLIONS) FIGURE 5 SHARE OF SEGMENTS IN U.S. PRESCRIPTION DERMATOLOGY MARKET, 2008 AND 2013 (%) FIGURE 5 (CONTINUED) FIGURE 6 LEADING PRESCRIPTION DRUG REVENUES IN GLOBAL DERMATOLOGY MARKET, 2008 ($ MILLIONS) Dermatological Therapeutics: Global Markets Page 20/28
  • 21. ReportLinker Find Industry reports, Company profiles and Market Statistics FIGURE 6 (CONTINUED) ENBREL FIGURE 7 ENBREL SALES IN GLOBAL DERMATOLOGY MARKET BY GEOGRAPHY, 2008 (%, TOTAL REVENUE = $ 3,230 MILLION) BOTOX FIGURE 8 BOTOX SALES IN THE GLOBAL DERMATOLOGY MARKET BY GEOGRAPHY, 2008 (%, TOTAL REVENUE = $ 1,200 MILLION FIGURE 8 (CONTINUED) LOCERYL FIGURE 9 LOCERYL SALES IN GLOBAL DERMATOLOGY MARKET BY GEOGRAPHY, 2008 (%, TOTAL = $350 MILLION FIGURE 10 GLOBAL DERMATOLOGICAL PRESCRIPTION MARKET BY REGIONAL SHARE'FUTURE OUTLOOK, 2011 (%) TABLE 59 MARKET SHARE OF PRESCRIPTION DRUG MANUFACTURERS, 2005-2007 ($ MILLIONS) GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET FIGURE 11 GLOBAL DERMATOLOGICAL MARKET BY REGIONAL SHARE, 2008 (%) TABLE 60 GLOBAL DERMATOLOGICAL THERAPEUTICS REVENUE FORECAST BY MARKET SEGMENT, THROUGH 2013 FIGURE 12 GLOBAL PRESCRIPTION DERMATOLOGY MARKET SHARE BY SEGMENT, 2008 (%) FIGURE 12 (CONTINUED) GLOBAL DERMATOLOGICAL ' (CONTINUED) GLOBAL DERMATOLOGICAL ' (CONTINUED) LIST OF TABLES SUMMARY TABLE GLOBAL DERMATOLOGICAL THERAPEUTICS REVENUE FORECAST BY MARKET SEGMENT, THROUGH 2013 Dermatological Therapeutics: Global Markets Page 21/28
  • 22. ReportLinker Find Industry reports, Company profiles and Market Statistics ($ BILLIONS) TABLE 1 FUNCTIONS OF THE SKIN TABLE 2 DISORDERS OF THE SKIN TABLE 3 TYPES OF ACNE TABLE 4 TYPES OF ROSACEA TABLE 5 DRUGS AND THEIR ACTION AGAINST ACNE AND ROSACEA TABLE 6 TYPES OF BACTERIAL INFECTIONS OF THE SKIN TABLE 7 SOME PRESCRIPTION DRUGS PRESCRIBED TO TREAT BACTERIAL SKIN INFECTIONS TABLE 8 TYPES OF BENIGN SKIN GROWTHS OR TUMORS TABLE 9 SOME PRESCRIPTION DRUGS USED TO TREAT BENIGN SKIN GROWTHS TABLE 10 TYPES OF BULLOUS DISORDERS TABLE 11 SOME PRESCRIPTION DRUGS USED TO TREAT BULLOUS SKIN DISORDERS TABLE 12 TYPES OF SKIN CANCERS TABLE 13 SKIN CANCER INCIDENCE IN THE U.S. TABLE 14 SOME PRESCRIPTION DRUGS USED TO TREAT CUTANEOUS CARCINOMAS TABLE 15 TYPES OF CALLUSES AND CORNS TABLE 16 TYPES OF ICHTHYOSIS TABLE 17 TYPES OF KERATOSIS PILARIS TABLE 18 TYPES OF DERMATITIS TABLE 19 SOME DRUGS PRESCRIBED FOR DERMATITIS TABLE 20 TYPES OF FUNGAL INFECTIONS OF THE SKIN Dermatological Therapeutics: Global Markets Page 22/28
  • 23. ReportLinker Find Industry reports, Company profiles and Market Statistics TABLE 21 SOME DRUGS PRESCRIBED TO TREAT FUNGAL INFECTIONS OF THE SKIN TABLE 22 TYPES OF DRUG REACTIONS AND TYPICAL CAUSATIVE AGENTS TABLE 23 TYPES OF ERYTHEMA MULTIFORME TABLE 24 SOME DRUGS PRESCRIBED TO TREAT HYPERSENSITIVITY AND INFLAMMATORY DISORDERS TABLE 25 TYPES OF PARASITIC INFECTION OF THE SKIN TABLE 26 SOME DRUGS PRESCRIBED TO TREAT PARASITIC INFECTIONS OF THE SKIN TABLE 27 TYPES OF PSORIASIS AND SCALING DISEASES TABLE 28 TYPES OF PIGMENTATION DISORDERS TABLE 29 SOME PRESCRIPTION DRUGS FOR PIGMENTATION DISORDERS TABLE 30 TYPES OF PHOTOSENSITIVITY TABLE 31 TYPES OF SWEATING DISORDERS TABLE 32 TYPES OF VIRAL SKIN DISEASES TABLE 33 SOME DRUGS PRESCRIBED TO TREAT VIRAL DISEASES OF THE SKIN TABLE 34 SKIN DISORDER MORBIDITY IN THE U.S. BY AGE AND CAUSE (THOUSANDS) TABLE 35 SKIN CONDITIONS REQUIRING ONLY LASER SURGERY TABLE 36 ADVANTAGES AND DISADVANTAGES OF EXCIMER LASER TABLE 37 VARIOUS CANCERS TREATABLE BY PDT TABLE 38 VARIOUS SKIN DISORDERS TREATABLE BY PDT Dermatological Therapeutics: Global Markets Page 23/28
  • 24. ReportLinker Find Industry reports, Company profiles and Market Statistics TABLE 39 ADVANTAGES AND DISADVANTAGES OF UVB THERAPY TABLE 40 ADVANTAGES AND DISADVANTAGES OF CYCLOSPORINE TABLE 41 ADVANTAGES AND DISADVANTAGES OF METHOTREXATE TABLE 42 ADVANTAGES AND DISADVANTAGES OF ANTHRALIN TABLE 43 ADVANTAGES AND DISADVANTAGES OF COAL TAR TABLE 44 ADVANTAGES AND DISADVANTAGES OF CORTICOSTEROIDS TABLE 45 TOPICAL CORTICOSTEROIDS, 2004 TABLE 46 ADVANTAGES AND DISADVANTAGES OF TAZAROTENE TABLE 47 ADVANTAGES AND DISADVANTAGES OF CALCIPOTRIOL TABLE 48 DRUG TREATMENTS FOR SKIN DISEASE INTRODUCED IN 2006 TABLE 49 NEW TECHNOLOGIES IN DERMATOLOGY TABLE 50 NUMBER OF U.S. PATENTS ISSUED, 2003 TO JULY 31, 2008 TABLE 51 COMPANIES AND NUMBER OF U.S. PATENTS FILED BY THEM, 2003 TO JULY 31, 2008 TABLE 52 RECENT DERMATOLOGY U.S. PATENTS TABLE 53 EUROPEAN DERMATOLOGICAL PATENTS, 2003-JULY 2008 TABLE 54 RECENT PATENTS ISSUED BY THE EPO TABLE 55 DERMATOLOGICAL ASSOCIATIONS TABLE 56 SIGNIFICANT MERGERS AND ACQUISITIONS (2005-2008) TABLE 57 LEADING DRUGS PRESCRIBED BY OFFICE-BASED DERMATOLOGISTS'ALL INDICATIONS, 2008 (THOUSANDS) Dermatological Therapeutics: Global Markets Page 24/28
  • 25. ReportLinker Find Industry reports, Company profiles and Market Statistics TABLE 58 U.S. DERMATOLOGICAL THERAPEUTICS MARKET: REVENUE FORECAST BY MARKET SEGMENT, THROUGH 2013 ($ BILLIONS) TABLE 59 MARKET SHARE OF PRESCRIPTION DRUG MANUFACTURERS, 2005-2007 ($ MILLIONS) TABLE 60 GLOBAL DERMATOLOGICAL THERAPEUTICS REVENUE FORECAST BY MARKET SEGMENT, THROUGH 2013 LIST OF FIGURES SUMMARY FIGURE GLOBAL DERMATOLOGICAL THERAPEUTICS REVENUE FORECAST BY MARKET SEGMENT, 2008 AND 2013 (%) FIGURE 1 GASTROINTESTINAL PERMEATION ENHANCEMENT TECHNOLOGY FIGURE 2 U.S. PATENT TRENDS, 1990-2001 FIGURE 3 PRESCRIBING OF ORAL ANTIBIOTICS FOR THE INTITIAL TREATMENT OF ACNE: CURRENT AND IN 1 YEAR (N=75) FIGURE 4 PRESCRIBING OF TOPICAL ANTIBIOTICS/RETINOIDS FOR ACNE: CURRENT AND IN 1 YEAR (N=75) FIGURE 5 SHARE OF SEGMENTS IN U.S. PRESCRIPTION DERMATOLOGY MARKET, 2008 AND 2013 (%) FIGURE 6 LEADING PRESCRIPTION DRUG REVENUES IN GLOBAL DERMATOLOGY MARKET, 2008 ($ MILLIONS) FIGURE 7 ENBREL SALES IN GLOBAL DERMATOLOGY MARKET BY GEOGRAPHY, 2008 (%, TOTAL REVENUE = $ 3,230 MILLION) FIGURE 8 BOTOX SALES IN THE GLOBAL DERMATOLOGY MARKET BY GEOGRAPHY, 2008 (%, TOTAL REVENUE = $ 1,200 MILLION Dermatological Therapeutics: Global Markets Page 25/28
  • 26. ReportLinker Find Industry reports, Company profiles and Market Statistics FIGURE 9 LOCERYL SALES IN GLOBAL DERMATOLOGY MARKET BY GEOGRAPHY, 2008 (%, TOTAL = $350 MILLION FIGURE 10 GLOBAL DERMATOLOGICAL PRESCRIPTION MARKET BY REGIONAL SHARE'FUTURE OUTLOOK, 2011 (%) FIGURE 11 GLOBAL DERMATOLOGICAL MARKET BY REGIONAL SHARE, 2008 (%) FIGURE 12 GLOBAL PRESCRIPTION DERMATOLOGY MARKET SHARE BY SEGMENT, 2008 (%) Dermatological Therapeutics: Global Markets Page 26/28
  • 27. ReportLinker Find Industry reports, Company profiles and Market Statistics Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to . If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Product Formats Please select the product formats and the quantity you require. Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________ Dermatological Therapeutics: Global Markets (805) 617 17 93 Digital Copy--USD 4 850.00 Quantity: _____ Hard Copy--USD 4 850.00 Quantity: _____ Corporate License--USD 8 500.00 Quantity: _____ Dermatological Therapeutics: Global Markets Page 27/28
  • 28. ReportLinker Find Industry reports, Company profiles and Market Statistics Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to Customer signature:   Crédit Mutuel RIB : 10278 07314 00020257701 78 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 178 (805) 617 17 93 Dermatological Therapeutics: Global Markets Page 28/28

×